Science continues to explore new avenues to improve the quality of life for people with celiac disease. One of the most striking advances comes from Córdoba, where researchers are working with a variety of wheat modified through gene editing to reduce or eliminate gliadins, the proteins that trigger the immune response in celiac disease.
The proposal is ambitious: to develop a wheat that maintains its baking properties, but is much safer for those who cannot consume gluten. If it were to become established, the impact would be enormous, as it would allow traditional foods to be enjoyed again without needing to resort to alternative flour blends.
However, the research is still in an experimental phase. Specialists emphasize that, for now, there is no commercial wheat suitable for celiacs and that the only safe diet remains a strictly gluten-free one. Even so, the project opens up a very promising line of work for both nutrition and sustainable agriculture.
This type of development also raises scientific and regulatory debates. Gene editing offers new possibilities, but requires comprehensive safety evaluations before its potential market release. It’s not just about creating a ‘different’ wheat, but about demonstrating that it is truly harmless for an especially vulnerable population.
This advance has sparked interest in the medical and food sectors because it points to a possible structural transformation of the market. For millions of people with celiac disease worldwide, any progress in this direction represents a hope, albeit a distant one. For now, prudence remains as necessary as research.
More celiac research worth following: does a single bread crumb affect celiacs? and an experimental drug that could protect the whole body from gluten’s effects, or which wheat components may be to blame in non-celiac gluten sensitivity.
Source: research by the Institute of Sustainable Agriculture of Córdoba, January 2026.
